glp-1 and multiple sclerosis GLP-1s Role of glucagon-like peptide-1 receptor

Quick Summary GLP-1 medications have powerful metabolic benefits and real potential side effects

FDA announced it is hosting a two-day hybrid workshop in partnership with the University of Maryland Center of Excellence in Regulatory Science and Innovation to discuss developing antihypertensive therapies for pediatric patients

Looking further ahead, researchers are focusing on developing GLP-1 drugs specifically engineered to better penetrate the central nervous system

Systemic lupus erythematosus and "lupus dyslipoproteinemia

Studies on primary cultures of orbital fibroblasts from TAO patients have shown that vitamin C, N-acetylcysteine and melatonin reduce H 2 O 2 -stimulated glutathione disulphide (GSSG) release, potentially benefiting orbital lesion treatment (130)